




<rss xmlns:a10="http://www.w3.org/2005/Atom" version="2.0">
    <channel>
        <title>Heart Failure and Cardiomyopathies</title>
        <link>http://www.acc.org/Feed?clinicalTopicID=f726f673-7e11-4292-84ae-69b198c58cf7</link>
        <description>Clinical Topic Feed: Heart Failure and Cardiomyopathies</description>
        <language>en</language>

        

                <item>
                    <title>Eagle&#226;€™s Eye View: Clopidogrel vs. Aspirin Following PCI</title>
<link>/Latest-in-Cardiology/Articles/2026/07/01/12/47/eagles-eye-view-01jul2026</link>                    <description>In this week&#226;€™s View, Dr. Eagle looks at how genotype independently predicts heart failure outcomes in patients with hypertrophic cardiomyopathy (HCM).</description>
                    <pubdate>1782910140000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Quality Improvement For Institutions | New Cardiogenic Shock Designation Addresses Deadly Gap in Chest Pain Care</title>
<link>/Latest-in-Cardiology/Articles/2026/07/01/01/Quality-Improvement-For-Institutions</link>                    <description>The ACC has announced a new Cardiogenic Shock Designation to improve outcomes for one of the most life-threatening complications of myocardial infarction. The new designation builds on the success of the ACC Chest Pain Center Accreditation, which has helped hospitals standardize and improve care...</description>
                    <pubdate>1782907980000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Heart of Health Policy | ACC Urges Changes as Ambulatory Specialty Model Approaches</title>
<link>/Latest-in-Cardiology/Articles/2026/07/01/01/Heart-of-Health-Policy</link>                    <description>With the mandatory Ambulatory Specialty Model (ASM) for Heart Failure (HF) slated to begin Jan. 1, 2027, the ACC is prioritizing member awareness and education, while pressing the Centers for Medicare and Medicaid Services (CMS) to address key issues with the model&#39;s design and requirements.</description>
                    <pubdate>1782907860000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>JACC in a Flash | Consistent Renal Benefit With Semaglutide in T2D/CKD; Late Pericardial Effusion Post LAAO</title>
<link>/Latest-in-Cardiology/Articles/2026/07/01/01/JACC-in-a-Flash</link>                    <description>Featured topics and Editors&#39; Picks from all of ACC&#39;s JACC Journals.</description>
                    <pubdate>1782907800000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Journal Wrap | PAD Screening Marker; Racial, Sex Disparities in M-TEER; More</title>
<link>/Latest-in-Cardiology/Articles/2026/07/01/01/Journal-Wrap</link>                    <description>The hottest research from various peer-reviewed journals &#226;€“ handpicked weekly by the ACC.</description>
                    <pubdate>1782907740000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>ACC Featured Jobs For July 2026</title>
<link>/Latest-in-Cardiology/Articles/2022/01/01/01/01/ACC-Featured-Jobs</link>                    <description>Ready to explore a new professional opportunity? Browse the list below of featured jobs and take the next step in your career!</description>
                    <pubdate>1782902880000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Do Patients With Reduced LVEF Undergoing LAAO Suffer Worse Outcomes?</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/06/29/15/38/Patients-With-Reduced-LVEF-Undergoing-LAAO</link>                    <description>There was no significant difference in procedural success, major in-hospital complications or stroke at one year in patients undergoing transcatheter left atrial appendage occlusion (LAAO) with reduced LVEF; however, these patients did exhibit higher mortality at one year...</description>
                    <pubdate>1782845400000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>GOAL-HF1: Novel Ghrelin Receptor Agonist Safe, Well-Tolerated Among Patients With HFrEF</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/06/29/15/38/GOAL-HF1</link>                    <description>AC01, a novel oral calcium-sensitizing isotope and ghrelin receptor agonist designed to increase myocardial contractility, appeared safe and well-tolerated over a 28-day treatment period in patients with heart failure with reduced ejection fraction (HFrEF), according to results from a phase 1b/2a randomized trial published June 24 in The Lancet.</description>
                    <pubdate>1782845280000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>ACC Scientific Statement Guides Use of Antiplatelet Therapy in Managing ASCVD</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/06/29/15/38/ACC-Scientific-Statement-Guides-Use-of-Antiplatelet-Therapy</link>                    <description>A new ACC Scientific Statement focused on the management of atherosclerotic cardiovascular disease, aims to help clinicians overcome the perpetual challenge of balancing the risk of ischemia with the risk of bleeding in this patient population.</description>
                    <pubdate>1782828000000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Antiplatelet Therapy in the Management of Atherosclerotic Cardiovascular Disease: 2026 ACC Scientific Statement</title>
<link>https://www.jacc.org/doi/10.1016/j.jacc.2026.05.037</link>                    <description></description>
                    <pubdate>1782828000000</pubdate>
                    <category>Guidelines</category>
                </item>

    </channel>
</rss>